Johnson & Johnson to spin out consumer health business in new publicly traded company
Johnson & Johnson to spin out consumer health business in [...]
Johnson & Johnson to spin out consumer health business in [...]
Fierce Pharma Asia—Takeda’s Alunbrig pricing pact; Merck, Japan COVID pill [...]
AstraZeneca’s latest heart awareness campaign with fitness guru Bob Harper [...]
Late to the party: Europe on the verge of approving [...]
Biogen posts more Aduhelm biomarker data and a ‘correlation’ with [...]
Despite strong efficacy, dermatologist survey indicates Incyte’s Opzelura uptake may [...]
Lundbeck cuts 300 jobs to fuel Vyepti growth as CGRP [...]
Johnson & Johnson scores 60-day stay in high-profile talc litigation: [...]
Eli Lilly touts long-term safety data for Olumiant amid classwide [...]
AstraZeneca creates unit to handle its COVID-19 vaccines and antibody [...]